Exhaled breath volatile organic compound biomarkers in lung cancer

Journal of Breath Research

Volumn 6, Issue 2, 2012, Pages

  Mazzone, Peter J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; VOLATILE ORGANIC COMPOUND;

EXPIRED AIR; HUMAN; LUNG CANCER; PRIORITY JOURNAL; REVIEW; SPECTROMETRY;

EID: 84861464986     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/6/2/027106     Document Type: Review

References (62)

1. Jemal A, Siegel R, Xu J and Ward E 2011 Cancer statistics 2010 CA Cancer J. Clin. 60 277-300
2. Oken M M et al 2011 Screening by chest radiograph and lung cancer mortality. The prostate, lung, colorectal, and ovarian (PLCO) randomized trial J. Am. Med. Assoc. 306 1865-73
3. The National Lung Screening Trial Research Team 2011 Reduced lung cancer mortality with low-dose computed tomographic screening N. Engl. J. Med. 365 395-409
4. Gopal M, Abdullah S E, Grady J J and Goodwin J S 2010 Screening for lung cancer with low-dose computed tomography. A systematic review and meta-analysis of the baseline findings of randomized controlled trials J. Thorac. Oncol. 5 1233-9
5. Hall W B, Truitt S G, Scheunemann L P, Shah S A, Rivera M P, L A Parker and Carson S S 2009 The prevalence of clinically relevant incidental findings on chest computed tomographic angiograms ordered to diagnose pulmonary embolism Arch. Intern. Med. 169 1961-5
6. Iribarren C, Hlatky M A, Chandra M, Fair J M, Rubin G D, Go A S, Burt J R and Fortmann S P 2008 Incidental pulmonary nodules on cardiac computed tomography: prognosis and use Am. J. Med. 121 989-96
7. Pignon J P et al 2008 Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group J. Clin. Oncol. 26 3552-9
8. Scagliotti G V et al 2008 Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer J. Clin. Oncol. 26 3543-51
9. Ciuleanu T et al 2009 Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study Lancet 374 1432-40
10. Mok T S et al 2009 Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma N. Engl. J. Med. 361 947-57
11. Kwak E L et al 2010 Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N. Engl. J. Med. 363 1693-703
12. Goto I et al 1996 Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer Cancer Res. 56 3725-30 (Pubitemid 26272020)
13. Wang X et al 2010 Genetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer PLoS One e11934
14. Ho J C, Zheng S, Comhair S A A, Farver C and Erzurum S C 2001 Differential expression of manganese superoxide dismutase and catalase in lung cancer Cancer Res. 61 8578-85 (Pubitemid 33131142)
15. Martin R C G, Li Y, Liu Q, Barker D F, Doll M A and Hein D W 2010 Manganese superoxide dismutase expression as a function of genotype and lung cancer pathology Cancer Invest. 28 813-9
16. Lauderoute K et al 2006 5-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments Mol. Cell Biol. 26 5336-47
17. Weinberg F et al 2010 Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity Proc. Natl Acad. Sci. USA 107 1003428107
18. Patel M, Lu L, Zander D S, Sreerama L, Coco D and Moreb J S 2008 ALDH1A! and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors Lung Cancer 59 340-9 (Pubitemid 351335102)
19. Park J Y et al 2010 Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 null allele in a Japanese population Carcinomgenesis 31 660-5
20. Duarte I F et al 2010 Can nuclear magnetic resonance (NMR) spectroscopy reveal different metabolic signatures for lung tumours? Virchows Arch. 457 715-25
21. Jordan K W, Adkins C B, Su L, Halpern E F, Mark E J, Christiani D C and Cheng L L 2010 Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue-serum pairs Lung Cancer 68 44-50
22. An Z et al 2010 Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer J. Proteome Res. 9 4071-81
23. Yang Q, Shi X, Wang Y, Wang W, He H, Lu X and Xu G 2010 Urinary metabonomic study of lung cancer by a fully automatic hyphenated hydrophilic interaction/RPLC-MS system J. Sep. Sci. 33 1495-503
24. Smith D, Wang T, Sule-Suso J, Spanel P and El Haj A 2003 Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry Rapid Commun. Mass Spectrom. 17 845-50 (Pubitemid 36433170)
25. Chen X et al 2007 A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis Cancer 110 835-44 (Pubitemid 47257662)
26. Filipiak W et al 2008 Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro Cancer Cell Int. 8 17
27. Sponring A et al 2009 Release of volatile organic compounds from the lung cancer cell line NCI-H2087 Anticancer Res. 29 419-26
28. Filipiak W et al 2010 TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro Cancer Epidemiol. Biomarkers Prev. 19 182-95
29. Sponring A, Filipiak W, Ager C, Schubert J, Miekisch W, Amann A and Troppmair J 2010 Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells Cancer Biomarkers 7 153-61
30. Mazzone P J 2008 Progress in the development of a diagnostic test for lung cancer through the analysis of breath volatiles J. Breath Res. 3 doi:10.1088 /1752-7155/2/3/037014
31. Gordon S M, Szidon J P, Krotoszynski K, Gibbons R D and O'Neill H J 1985 Volatile organic compounds in exhaled air from patients with lung cancer Clin. Chem. 31 1278-82 (Pubitemid 16041914)
32. O'Neill J H, Gordono S M, O'Neill M H, Gibbons R D and Szidon J P 1988 A computerized classification technique for screening for the presence of breath biomarkers in lung cancer Clin. Chem. 34 1613-8
33. Preti G, Labows J N, Kostelc J G, Aldinger S and Daniele R 1988 Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectometry J. Chromatogr. 432 1-11
34. Phillips M et al 1999 Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study Lancet 353 1930-3 (Pubitemid 29255706)
35. Phillips M et al 2003 Detection of lung cancer with volatile markers in the breath Chest 123 2115-23 (Pubitemid 36706741)
36. Corradi M et al 2003 Volatile hydrocarbons in exhaled air: preliminary data on the characteristic profile associated with lung tumors G. Ital. Med. Lav. Ergon. 25S3 59-60
37. Poli D et al 2005 Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study Respir. Res. 6 71
38. Phillips M et al 2007 Prediction of lung cancer using volatile biomarkers in breath Cancer Biomarkers 3 95-109 (Pubitemid 47103811)
39. Chen X et al 2007 A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis Cancer 110 835-44 (Pubitemid 47257662)
40. Wehinger A et al 2007 Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas J. Mass Spectrom. 265 49-59
41. Peng G, Trock E and Haick H 2008 Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with nonpolymeric organic materials Nano Lett. 8 3631-5
42. Gaspar E M, Lucena A F, da Costa J D and das Neves C 2009 Organic metabolites in exhaled human breath-a multivariate approach for identification of biomarkers in lung disorders J. Chromatogr. A 1216 2749-56
43. Westhoff M, Litterst P, Freitag L, Urfer W, Bader S and Baumbach J I 2009 Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of lung cancer patients-results of a pilot study Thorax 64 744-8
44. Poli D et al 2008 Breath analysis in non small cell lung cancer patients after surgical tumour resection Acta Biomed. 79S1 64-72
45. Bajtarevic A et al 2009 Noninvasive detection of lung cancer by analysis of exhaled breath BMC Cancer 9 348
46. Ligor M et al 2009 Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry Clin. Chem. Lab. Med. 47 550-60
47. Song G et al 2010 Quantitative breath analysis of volatile organic compounds of lung cancer patients in China Lung Cancer 67 227-31
48. Poli D et al 2010 Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS J. Chromatogr. B 878 2643-51
49. Fuchs P, Loeseken C, Schubert J K and Miekisch W 2010 Breath gas aldehydes as biomarkers of lung cancer Int. J. Cancer 126 2663-70
50. Kischkel S, Miekisch W, Sawacki A, Straker EM, Trefz P, Amann A and Schubert J K 2010 Breath biomarkers for lung cancer detection and assessment of smoking related effects- confounding variables, influence of normalization and statistical algorithms Clin. Chim. Acta 411 1637-44
51. Peng G et al 2010 Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors Br. J. Cancer 103 542-51
52. Di Natale C et al 2003 Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors Biosens. Bioelectron. 18 1209-18 (Pubitemid 36776581)
53. Chen X et al 2005 A study of an electronic nose for detection of lung cancer based on a virtual SAW gas sensors array and imaging recognition method Meas. Sci. Technol. 16 1535-46 (Pubitemid 41053390)
54. Machado R F et al 2005 Detection of lung cancer by sensor array analyses of exhaled breath Am. J. Respir. Crit. Care Med. 171 1286-91 (Pubitemid 40740737)
55. Mazzone P J, Hammel J, Dweik R A, Na J, Czich C, Laskowski D and Mekhail T 2007 Lung cancer diagnosis by the analysis of exhaled breath with a colorimetric sensor array Thorax 62 565-8 (Pubitemid 47056880)
56. Dragonieri S et al 2009 An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD Lung Cancer 64 166-70
57. Peng G et al 2009 Diagnosing lung cancer in exhaled breath using gold nanoparticles Nature Nanotechnol. 4 669-73
58. D'Amico A et al 2010 An investigation on electronic nose diagnosis of lung cancer Lung Cancer 68 170-6
59. Mazzone P J et al 2012 Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer J. Thorac. Oncol. 7 137-42
60. McCulloch M, Jezierski T, Broffman M, Hubbard A, Turner K and Janecki T 2006 Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers Integr. Cancer Ther. 5 30-9 (Pubitemid 43260792)
61. Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G and Walles T Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon Eur. Respir. J. doi: 10.1183/09031936.00051711
62. Mazzone P J 2010 Eur. Respir. Mon. 49 130-9 chapter 9